|
|
Analysis of related factors affecting the diagnosis and pathological upgrading of atypical endometrial hyperplasia |
ZHANG Yue-hua1 WANG Lu-yi1▲ ZHANG Se-hua2 |
1.Department of Pathology, Foshan First People′s Hospital in Guangdong Province, Foshan 528000, China;
2.Department of Pharmacy, Guicheng Hospital of Nanhai District in Foshan City, Guangdong Province, Foshan 528000, China |
|
|
Abstract Objective To analyze the related factors affecting the diagnosis and pathological upgrading of atypical endometrial hyperplasia (AEH).Methods The clinical data of 88 patients with AEH who were initially diagnosed in the Department of Gynecology of Foshan First People′s Hospital in Guangdong Province from December 2015 to December 2018 were retrospectively analyzed.According to the results of postoperative pathological diagnosis, the patients were divided into endometrial carcinoma (EC) group (31 cases) and AEH group (57 cases).The related factors of AEH pathological upgrading were analyzed.Results There was no significant difference in the level of high-density lipoprotein(HDL-C) and hypertension between the two groups (P>0.05).The age and endometrial thickness of patients in the EC group were higher than those in the AEH group, and triglycerides (TG), total cholesterol (CHOL), low-density lipoprotein (LDL-C), body mass index (BMI), menopausal rate, and diabetes incidence were higher than those in AEH group,the differences were statistically significant (P<0.05).Age≥50 years old (β=1.05, OR=2.88, 95%CI 1.11-7.62), BMI>25 kg/m2(β=1.35, OR=3.96, 95%CI 1.27-12.66), menopausal status (β=2.72, OR=15.59, 95%CI 2.04-118.52), diabetes(β=1.62, OR=5.97, 95%CI 2.75-16.32), endometrial thickening (β=1.12, OR=3.49, 95%CI 0.76-6.33) and abnormal lipid metabolism (β=1.79, OR=6.13, 95%CI 2.04-17.92) were the risk factors of postoperative pathological progression to EC in patients with AEH (P<0.05).Conclusion Women over 50 years old (especially in menopause), with symptoms such as abnormal uterine bleeding, dyslipidemia, endometrial thickening, obesity, diabetes and so on, have a higher probability of pathological upgrading to EC in patients with AEH.It is suggested that hysteroscopic assisted curettage should be used.If necessary, pathological examination should be frozen quickly to reduce the rate of missed diagnosis or misdiagnosis, so as to correctly diagnose and treat patients as early as possible.
|
|
|
|
|
[1] |
方清敏,陶涛,杨琳.子宫内膜病变相关因素的分析[J].中国实用医药,2017,12(14):72-73.
|
[2] |
曹冬焱,俞梅,杨佳欣,等.大剂量孕激素治疗早期子宫内膜癌及子宫内膜重度不典型增生患者的妊娠结局及相关因素分析[J].中华妇产科杂志,2013,48(7):519-522.
|
[3] |
梁晓兰.子宫内膜息肉并发子宫内膜不典型增生危险因素探讨[J].卫生职业教育,2019,37(2):158-159.
|
[4] |
张薇.围绝经期妇女子宫内膜息肉伴子宫内膜增生过长相关影响因素Logistic 回归分析[J].现代医药卫生,2016,32(17):2720-2721.
|
[5] |
周莹,冯凤芝,金滢,等.子宫内膜增生并发子宫内膜癌的高危因素及预后分析[J].实用妇产科杂志,2016,32(11):826-829.
|
[6] |
郭秀玲,张妍.子宫内膜增生症中不同影响因素和不同治疗方法的临床疗效观察[J].齐齐哈尔医学院学报,2017,38(17):1998-2000.
|
[7] |
任王静,刘娟,闵爱萍,等.子宫内膜增生患者术后诊断为子宫内膜癌的危险因素探讨[J].妇产与遗传(电子版),2017,7(3):20-24.
|
[8] |
何翊姣,王建六.子宫内膜非典型增生及早期子宫内膜癌保守治疗复发的相关因素及临床处理的研究进展[J].中华妇产科杂志,2018,53(12):878-880.
|
[9] |
王慧,郭秀玲.子宫内膜增生症中不同因素及治疗方法与临床效果的相关性研究[J].泰山医学院学报,2018,39(2):136-138.
|
[10] |
孙志红,张玉凤.活检子宫内膜增生患者术后并发子宫内膜癌的危险因素及病理特点分析[J].中国妇幼保健,2018,33(20):4626-4629.
|
[11] |
徐海洋.子宫内膜增生合并子宫内膜癌的相关危险因素分析[J].实用妇科内分泌电子杂志,2018,5(33):52-54.
|
[12] |
张爱玲.子宫内膜增生合并子宫内膜癌的相关危险因素分析[J].卫生职业教育,2018,36(4):149-151.
|
[13] |
郭芳.子宫内膜增生合并子宫内膜癌的相关危险因素分析[J].实用妇科内分泌电子杂志,2018,5(30):146-147.
|
[14] |
翟芬菊,李彩菊,杨利.子宫内膜增生相关因素分析[J].中国妇幼保健,2012,27(16):2455-2456.
|
[15] |
李玲,杨兴升,孙清,等.子宫内膜不典型增生患者的内膜癌漏诊因素分析[J].现代妇产科进展,2014,23(7):553-555.
|
[16] |
陆林,陈相英,陈昭日.影响子宫内膜不典型增生诊断及病理升级的相关因素分析[J].潍坊医学院学报,2017,39(2):129-131.
|
|
|
|